AstraZeneca Historical Income Statement

AZN Stock  USD 67.75  0.51  0.75%   
Historical analysis of AstraZeneca PLC income statement accounts such as Interest Expense of 1.7 B, Total Revenue of 24.2 B or Gross Profit of 19.9 B can show how well AstraZeneca PLC ADR performed in making a profits. Evaluating AstraZeneca PLC income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of AstraZeneca PLC's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining AstraZeneca PLC ADR latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AstraZeneca PLC ADR is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

About AstraZeneca Income Statement Analysis

AstraZeneca PLC ADR Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to AstraZeneca PLC shareholders. The income statement also shows AstraZeneca investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

AstraZeneca PLC Income Statement Chart

AstraZeneca PLC ADR Income Statement is one of the three primary financial statements used for reporting AstraZeneca's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AstraZeneca PLC ADR revenue and expense. AstraZeneca PLC Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, AstraZeneca PLC's Interest Income is very stable compared to the past year.

Total Revenue

Total revenue comprises all receipts AstraZeneca PLC ADR generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of AstraZeneca PLC ADR minus its cost of goods sold. It is profit before AstraZeneca PLC operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of AstraZeneca PLC ADR. It is also known as AstraZeneca PLC overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from AstraZeneca PLC ADR operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of AstraZeneca PLC ADR is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most accounts from AstraZeneca PLC's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into AstraZeneca PLC ADR current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
At this time, AstraZeneca PLC's Interest Income is very stable compared to the past year.
 2021 2022 2023 2024 (projected)
Interest Expense1.3B1.3B1.6B1.7B
Depreciation And Amortization6.5B5.6B4.9B5.2B

AstraZeneca PLC income statement Correlations

0.510.720.620.81-0.13-0.10.850.330.78-0.16-0.47-0.13-0.270.720.8-0.170.760.07-0.17-0.380.260.83-0.36
0.510.430.430.420.110.140.750.30.430.01-0.860.09-0.230.280.30.40.320.370.130.120.210.47-0.46
0.720.430.980.960.390.410.760.760.960.33-0.240.40.060.890.81-0.320.890.19-0.17-0.510.240.64-0.15
0.620.430.980.890.520.550.730.840.920.47-0.180.530.190.840.69-0.310.840.32-0.02-0.440.160.53-0.22
0.810.420.960.890.10.120.760.540.990.04-0.350.12-0.20.930.9-0.290.950.05-0.32-0.540.330.75-0.09
-0.130.110.390.520.10.990.140.870.140.990.330.990.830.08-0.06-0.170.020.410.34-0.04-0.21-0.2-0.18
-0.10.140.410.550.120.990.190.880.170.980.310.980.820.11-0.06-0.190.050.470.39-0.05-0.23-0.18-0.24
0.850.750.760.730.760.140.190.480.770.09-0.550.14-0.120.730.71-0.180.730.460.09-0.380.040.79-0.65
0.330.30.760.840.540.870.880.480.570.830.10.860.620.450.33-0.220.430.340.18-0.210.020.18-0.19
0.780.430.960.920.990.140.170.770.570.08-0.360.15-0.170.940.84-0.290.960.15-0.21-0.50.290.71-0.15
-0.160.010.330.470.040.990.980.090.830.080.430.990.870.05-0.09-0.24-0.020.410.36-0.06-0.28-0.23-0.19
-0.47-0.86-0.24-0.18-0.350.330.31-0.550.1-0.360.430.350.61-0.22-0.26-0.54-0.29-0.120.08-0.16-0.4-0.450.2
-0.130.090.40.530.120.990.980.140.860.150.990.350.780.11-0.03-0.170.040.410.26-0.04-0.25-0.2-0.15
-0.27-0.230.060.19-0.20.830.82-0.120.62-0.170.870.610.78-0.18-0.28-0.35-0.230.260.58-0.07-0.24-0.34-0.19
0.720.280.890.840.930.080.110.730.450.940.05-0.220.11-0.180.86-0.490.970.25-0.18-0.680.130.71-0.23
0.80.30.810.690.9-0.06-0.060.710.330.84-0.09-0.26-0.03-0.280.86-0.390.87-0.06-0.46-0.670.290.9-0.11
-0.170.4-0.32-0.31-0.29-0.17-0.19-0.18-0.22-0.29-0.24-0.54-0.17-0.35-0.49-0.39-0.4-0.16-0.180.830.18-0.240.23
0.760.320.890.840.950.020.050.730.430.96-0.02-0.290.04-0.230.970.87-0.40.17-0.22-0.580.260.75-0.2
0.070.370.190.320.050.410.470.460.340.150.41-0.120.410.260.25-0.06-0.160.170.6-0.1-0.410.07-0.8
-0.170.13-0.17-0.02-0.320.340.390.090.18-0.210.360.080.260.58-0.18-0.46-0.18-0.220.60.04-0.29-0.27-0.62
-0.380.12-0.51-0.44-0.54-0.04-0.05-0.38-0.21-0.5-0.06-0.16-0.04-0.07-0.68-0.670.83-0.58-0.10.04-0.11-0.510.13
0.260.210.240.160.33-0.21-0.230.040.020.29-0.28-0.4-0.25-0.240.130.290.180.26-0.41-0.29-0.110.270.43
0.830.470.640.530.75-0.2-0.180.790.180.71-0.23-0.45-0.2-0.340.710.9-0.240.750.07-0.27-0.510.27-0.37
-0.36-0.46-0.15-0.22-0.09-0.18-0.24-0.65-0.19-0.15-0.190.2-0.15-0.19-0.23-0.110.23-0.2-0.8-0.620.130.43-0.37
Click cells to compare fundamentals

AstraZeneca PLC Account Relationship Matchups

AstraZeneca PLC income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization4.1B3.2B6.5B5.6B4.9B5.2B
Interest Expense1.4B1.3B1.3B1.3B1.6B1.7B
Total Revenue24.4B26.6B37.4B44.4B45.8B24.2B
Gross Profit19.5B21.3B25.0B32.0B37.5B19.9B
Other Operating Expenses21.2B21.5B36.4B40.6B37.1B19.0B
Operating Income2.9B5.2B1.1B3.8B8.2B5.0B
Ebit2.9B5.2B1.1B3.8B9.0B5.4B
Research Development6.0B6.0B9.7B9.8B10.9B11.5B
Ebitda7.0B8.4B7.6B9.3B13.9B7.7B
Total Operating Expenses16.3B16.2B23.9B28.2B28.8B14.7B
Income Before Tax1.5B3.9B(265M)2.5B6.9B4.5B
Total Other Income Expense Net(1.4B)(1.2B)(1.3B)(1.3B)(1.3B)(1.2B)
Net Income1.3B3.2B112M3.3B6.0B3.5B
Income Tax Expense321M772M(380M)(792M)938M729.2M
Selling General Administrative9.0B11.7B15.7B19.0B18.2B11.8B
Cost Of Revenue4.9B5.3B12.4B12.4B8.3B6.4B
Net Income Applicable To Common Shares1.3B3.2B112M3.3B3.0B3.2B
Minority Interest1.5B16M(3M)(5M)(6M)(5.7M)
Selling And Marketing Expenses11.8B11.7B15.7B19.0B18.2B11.9B
Net Income From Continuing Ops1.2B3.1B115M3.3B6.0B6.3B
Tax Provision321M772M(380M)(792M)938M984.9M
Interest Income774M87M43M95M301M342.8M
Net Interest Income(1.2B)(1.2B)(1.3B)(1.3B)(1.3B)(1.4B)
Reconciled Depreciation3.8B3.1B6.5B5.5B4.9B4.8B

AstraZeneca PLC Investors Sentiment

The influence of AstraZeneca PLC's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AstraZeneca. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AstraZeneca PLC's public news can be used to forecast risks associated with an investment in AstraZeneca. The trend in average sentiment can be used to explain how an investor holding AstraZeneca can time the market purely based on public headlines and social activities around AstraZeneca PLC ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AstraZeneca PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AstraZeneca PLC's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AstraZeneca PLC's news discussions. The higher the estimated score, the more favorable is the investor's outlook on AstraZeneca PLC.

AstraZeneca PLC Implied Volatility

    
  21.4  
AstraZeneca PLC's implied volatility exposes the market's sentiment of AstraZeneca PLC ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if AstraZeneca PLC's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that AstraZeneca PLC stock will not fluctuate a lot when AstraZeneca PLC's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AstraZeneca PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AstraZeneca PLC's short interest history, or implied volatility extrapolated from AstraZeneca PLC options trading.

Pair Trading with AstraZeneca PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.

Moving against AstraZeneca Stock

  0.48MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC ADR to buy it.
The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AstraZeneca PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AstraZeneca PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AstraZeneca PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.059
Dividend Share
2.9
Earnings Share
1.9
Revenue Per Share
2.4547
Quarterly Revenue Growth
0.073
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.